Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2014 2
2015 2
2020 1
2021 1
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR; PARALLAX Investigators and Committee members. Pieske B, et al. JAMA. 2021 Nov 16;326(19):1919-1929. doi: 10.1001/jama.2021.18463. JAMA. 2021. PMID: 34783839 Free PMC article. Clinical Trial.
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Velicki L, Popovic D, Okwose NC, Preveden A, Tesic M, Tafelmeier M, Charman SJ, Barlocco F, MacGowan GA, Seferovic PM, Filipovic N, Ristic A, Olivotto I, Maier LS, Jakovljevic DG; SILICOFCM Investigators. Velicki L, et al. Eur J Heart Fail. 2024 Jun;26(6):1361-1368. doi: 10.1002/ejhf.3291. Epub 2024 May 27. Eur J Heart Fail. 2024. PMID: 38800948 Free article. Clinical Trial.
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.
Tafelmeier M, Baessler A, Wagner S, Unsoeld B, Preveden A, Barlocco F, Tomberli A, Popovic D, Brennan P, MacGowan GA, Ristic A, Velicki L, Olivotto I, Jakovljevic DG, Maier LS. Tafelmeier M, et al. Among authors: unsoeld b. Clin Cardiol. 2020 May;43(5):430-440. doi: 10.1002/clc.23346. Epub 2020 Mar 3. Clin Cardiol. 2020. PMID: 32125709 Free PMC article.
First experience with the Synergy Micro-Pump in patients in INTERMACS class 1-2 as a bridge to transplantation: pushing the limits?
Sabashnikov A, Popov AF, Bowles CT, Weymann A, Mohite PN, Wahlers T, Wittwer T, Zych B, Garcia-Saez D, Patil NP, Fatullayev J, Amrani M, Banner NR, Seidler T, Unsoeld B, Bireta C, Schoendube FA, Simon AR. Sabashnikov A, et al. Among authors: unsoeld b. Artif Organs. 2015 Feb;39(2):118-25. doi: 10.1111/aor.12316. Epub 2014 May 20. Artif Organs. 2015. PMID: 24841499